Rapamycin induces morphological and physiological changes without increase in lipid content in Ustilago maydis

Arch Microbiol. 2020 Jul;202(5):1211-1221. doi: 10.1007/s00203-020-01833-y. Epub 2020 Feb 22.

Abstract

The evolutionarily conserved serine/threonine kinase TOR recruits different subunits to assemble the Target of Rapamycin Complex 1 (TORC1), which is inhibited by rapamycin and regulates ribosome biogenesis, autophagy, and lipid metabolism by regulating the expression of lipogenic genes. In addition, TORC1 participates in the cell cycle, increasing the length of the G2 phase. In the present work, we investigated the effect of rapamycin on cell growth, cell morphology and neutral lipid metabolism in the phytopathogenic fungus Ustilago maydis. Inhibition of TORC1 by rapamycin induced the formation of septa that separate the nuclei that were formed after mitosis. Regarding neutral lipid metabolism, a higher accumulation of triacylglycerols was not detected, but the cells did contain large lipid bodies, which suggests that small lipid bodies became fused into big lipid droplets. Vacuoles showed a similar behavior as the lipid bodies, and double labeling with Blue-CMAC and BODIPY indicates that vacuoles and lipid bodies were independent organelles. The results suggest that TORC1 has a role in cell morphology, lipid metabolism, and vacuolar physiology in U. maydis.

Keywords: Lipid droplets; Rapamycin; TOR; Ustilago maydis; Vacuoles.

MeSH terms

  • Antifungal Agents / pharmacology
  • Lipid Metabolism / drug effects*
  • Lipids / analysis
  • Mechanistic Target of Rapamycin Complex 1 / metabolism
  • Sirolimus / pharmacology*
  • Triglycerides / administration & dosage
  • Ustilago / chemistry
  • Ustilago / drug effects*
  • Vacuoles / chemistry

Substances

  • Antifungal Agents
  • Lipids
  • Triglycerides
  • Mechanistic Target of Rapamycin Complex 1
  • Sirolimus